WP1
Towards flexible, easily transferable multi-product technologies
• Modular glycan expression systems for bacterial vaccines
• Modular antigen display on protein nanoparticles
• Novel modular VLPs platforms
WP2
Towards integrated engineering platforms to automate manufacturing
• Rapid platform for pDNA production
• Automated microscale processing
• Integrated microfluidics for mRNA production
• Scalable GMP microfluidics platform particles production
• Reducing adenovirus impurities
WP3
Towards simplified regimens, extended shelf life and delivery at reduced waste
• Systems for microparticles encapsulation
• Novel spray- and freeze-dried formulations
• Microneedle array patch development